LOGIN
Intravenous Versus Perineural Dexmedetomidine As Adjuvant In Adductor Canal Block For TKA
September 2025
Intravenous Versus Perineural Dexmedetomidine As Adjuvant In Adductor Canal Block For TKA
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Intravenous versus perineural dexmedetomidine as adjuvant in adductor canal block for total knee arthroplasty.
Korean J Anesthesiol . 2023 Aug;76(4):307-316.Synopsis
Fifty-six patients with ASA I–II status scheduled for unilateral primary TKA were randomized to receive intravenous dexmedetomidine 0.5 µg/kg plus ACB with levobupivacaine (n=28) or perineural dexmedetomidine 0.5 µg/kg added to levobupivacaine in the ACB with intravenous saline (n=28). The primary outcome was shivering incidence 1 hour after spinal anesthesia. Secondary outcomes included shivering...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.